PIN1: Peptidylprolyl Cis/Trans Isomerase, NIMA-Interacting 1

A key regulator of protein conformation and cell cycle progression, implicated in cancer and neurodegeneration.

Gene Information Card

Symbol PIN1
Full Name Peptidylprolyl Cis/Trans Isomerase, NIMA-Interacting 1
Gene Type Protein coding
Chromosomal Location 19p13.2
NCBI Gene ID 5300 ncbi.nlm.nih.gov/gene/5300
Ensembl ID ENSG00000127445
UniProt ID Q13526
OMIM ID 601052
HGNC ID 8988
Aliases DOD, UBL5

Description

The PIN1 gene encodes a peptidylprolyl cis/trans isomerase that specifically isomerizes phosphorylated Ser/Thr-Pro bonds. This isomerization induces conformational changes in target proteins, regulating their activity, stability, and subcellular localization. PIN1 is essential for cell cycle progression and is implicated in various cancers and neurodegenerative disorders, including Alzheimer's disease.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (breast, prostate, lung, etc.) PIN1 overexpression or aberrant activity promotes oncogenic signaling by stabilizing and activating oncoproteins (e.g., cyclin D1, c-Jun, β-catenin) and inactivating tumor suppressors. Multiple studies (e.g., PMID: 12524533, PMID: 17016423)
Alzheimer's disease PIN1 dysfunction leads to tau hyperphosphorylation and neurofibrillary tangle formation; loss of PIN1 activity contributes to amyloid precursor protein processing and Aβ accumulation. PMID: 10591208, PMID: 17016423
Asthma PIN1 regulates airway inflammation by modulating NF-κB and AP-1 signaling in immune cells. PMID: 22121019

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 28.2 High
Lymph node 18.5 Medium
Brain (cerebellum) 15.3 Medium
Heart 12.1 Medium
Liver 8.4 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa (cervical carcinoma) 22.5 High expression
MCF7 (breast cancer) 19.8 High expression
HEK293 (embryonic kidney) 15.2 Medium expression
HepG2 (liver cancer) 12.7 Medium expression
K562 (leukemia) 9.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.145C>T (p.Arg49Cys) Missense <0.1% Reduced isomerase activity; associated with altered substrate binding.
c.202G>A (p.Glu68Lys) Missense <0.1% Potential loss of function; reported in cancer samples.
c.331G>A (p.Val111Met) Missense <0.1% Unknown functional effect; rare variant.
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Arg49Cys) reduce catalytic activity, impairing PIN1's ability to isomerize phospho-Ser/Thr-Pro motifs, leading to dysregulation of cell cycle and signaling.

Gain of Function (GOF)

Overexpression or amplification of wild-type PIN1 is common in cancers, acting as a gain-of-function by enhancing oncoprotein stability and promoting proliferation.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported; however, mutant forms with reduced activity may compete with wild-type PIN1 for substrate binding.

Pathways

• Cell cycle (KEGG: hsa04110)
• p53 signaling pathway (KEGG: hsa04115)
• Wnt signaling pathway (KEGG: hsa04310)
• Alzheimer disease (KEGG: hsa05010)
• Prostate cancer (KEGG: hsa05215)

Protein Summary

PIN1 is a 163-amino acid protein (18 kDa) that contains an N-terminal WW domain for phospho-Ser/Thr-Pro recognition and a C-terminal peptidyl-prolyl isomerase (PPIase) domain. It catalyzes the cis/trans isomerization of phosphorylated Ser/Thr-Pro bonds, inducing conformational changes that regulate protein function, stability, and localization. PIN1 is highly conserved and plays a pivotal role in cell cycle control, transcription, and cellular stress responses.

Related Products

Product name Cat.No. Species Gene ID
PIN1 Knockout HEK293 Cell Line EDJ-KQ2140 Human 5300 Details Get a Quote
PIN1 Knockout A-549 Cell Line EDJ-KQ22304 Human 5300 Details Get a Quote
PIN1 Knockout HCT 116 Cell Line EDJ-KQ22305 Human 5300 Details Get a Quote
PIN1 Knockout HeLa Cell Line EDJ-KQ22306 Human 5300 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: